Oral antibiotics in young infants
Treatments studied
Part of Infections clinical trials.
This study looks at how the body processes oral antibiotics in young babies. It aims to help doctors choose the right doses by studying how these medicines move through the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be 90 days old or younger and weigh at least 2 kilograms (about 4.4 pounds).
- Your baby must be in the hospital and receiving antibiotics.
- Your baby must be able to take medicines or feedings by mouth or through a feeding tube.
- Your baby must not have severe kidney or liver problems.
- Your baby must not have bowel conditions that prevent proper absorption of medicines.
- Your baby must not be on a heart-lung bypass machine (ECMO) or have uncontrolled medical instability.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adjusting the dose of linezolid based on regular blood tests can help people with multidrug-resistant tuberculosis (MDR-TB) tolerate the medication better while on the BPaL or BPaL-M regimen. It aims to reduce side effects and improve treatment success.
This study tests whether giving oral antibiotics at home is as safe and effective as the usual injections for newborns exposed to syphilis during pregnancy. It is for babies who appear healthy at birth.
This study tests whether giving zinc supplements to very young babies (under 2 months) with severe infections helps them recover better. It takes place in Tanzania and involves adding zinc to their regular care.
This study tests a new antibiotic called aztreonam-avibactam (ATM-AVI) for treating serious bacterial infections in hospitalized babies under 9 months old. The goal is to see if it's safe and works well.
This study is testing a way to adjust the dose of an antibiotic called linezolid for people on hemodialysis. The goal is to find the right dose to treat infections safely and effectively.
This study checks if measuring the amount of linezolid medicine in your blood helps treat rifampin-resistant tuberculosis more safely and effectively. It is for people who have already started a treatment plan that includes linezolid.
Hear when a new Linezolid Pharmacokinetics in Young Infants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.